INSM
NASDAQ · Biotechnology
Insmed Inc
$120.82
-0.18 (-0.15%)
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+18.7% upside
Low Target
$91.17
Average Target
$143.40
High Target
$177.14
Current Price
$120.82
Current
$120.82
$120.82
Target
$143.40
$143.40
$91.17
$143.40 avg
$177.14
Scenario Analysis
Bear Case
$91.17
-24.5%
Low target
Base Case
$143.40
+18.7%
Avg target
Bull Case
$177.14
+46.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$212.75
-43.2% from high
52-Week Low
$90.39
+33.7% from low
50-Day SMA
$168.11
-28.1% vs SMA
200-Day SMA
$139.54
-13.4% vs SMA
RSI (14)
54.8
Neutral
Target vs 52W High
$143.40
-32.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |